Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBank Irel13.375 Regulatory News (BOI)

Share Price Information for Bank Irel13.375 (BOI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 188.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 188.00
BOI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Offer Update

24 Nov 2006 07:00

3M UK Holdings PLC24 November 2006 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY ORINDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE AVIOLATION OF THE RELEVANT LAWS IN THAT JURISDICTION 24 November 2006 RECOMMENDED CASH OFFER FOR BIOTRACE INTERNATIONAL PLC BY 3M UK HOLDINGS PLC ADVISED BY UBS INVESTMENT BANK Offer Unconditional as to Acceptances 1. Offer Unconditional as to Acceptances 3M UK Holdings PLC ("3M") announces that as at 1.00 p.m. (London time) on 23November 2006, valid acceptances had been received in respect of, in aggregate,33,352,602 Biotrace Shares, representing approximately 84.83 per cent. ofBiotrace's issued share capital. None of these acceptances were received frompersons acting in concert with 3M. These Biotrace Shares represent in excess of90 per cent. of the Biotrace Shares to which the Offer relates and, accordingly,the Offer has become unconditional as to acceptances. As disclosed in the offer document dated 13 October 2006 (the "Offer Document"),at the time of the Offer, 3M had received irrevocable undertakings in respectof, in aggregate, 12,552,196 Biotrace Shares, representing approximately 31.93per cent. of Biotrace's issued share capital. Valid acceptances have beenreceived in respect of all of these Biotrace Shares. In addition, also as disclosed in the Offer Document, at the time of the Offer,3M had acquired 3,906,489 Biotrace Shares representing 9.94 per cent. ofBiotrace's issued share capital. Accordingly, as at 1.00 p.m. on 23 November 2006, 3M owned or had received validacceptances in respect of, in aggregate, 37,259,091 Biotrace Shares,representing approximately 94.77 per cent. of Biotrace's issued share capital. 2. Extension of the Offer The Offer remains open for acceptance until further notice. The Offer remainssubject to the conditions (other than the acceptance condition) and furtherterms set out in Part A and Part B of Appendix I to the Offer Document. Biotrace Shareholders who have not yet accepted the Offer and who hold BiotraceShares in certificated form are urged to complete, sign and return the Form ofAcceptance as soon as possible. If you hold Biotrace Shares in uncertificated form (that is, in CREST), you areurged to accept the Offer by TTE instructions as soon as possible. If you holdBiotrace Shares as a CREST sponsored member, you should refer to your CRESTsponsor as only your CREST sponsor will be able to send the necessary TTEinstruction to CREST. Copies of the Offer Document are available from Capita Registrars, The Registry,34 Beckenham Road, Beckenham, Kent, BR3 4TU. Terms defined in the Offer Document shall have the same meanings in thisannouncement. 3. Enquiries Capita Registrars Tel: 0870 162 3121 (if calling from within the United Kingdom) Tel: +44 20 8639 2157 (if calling from outside the United Kingdom) UBS Investment Bank Tel: +44 20 7567 8100 Contacts: Aidan Clegg, Nik Morandi UBS, which is authorised and regulated by the FSA, is acting exclusively for 3Mand no one else in connection with this announcement and will not be responsibleto anyone other than 3M for providing the protections afforded to clients of UBSor for providing advice in connection with this announcement or any othermatters referred to herein. Numis, which is authorised and regulated by the FSA, is acting exclusively forBiotrace and no one else in connection with this announcement and will not beresponsible to anyone other than Biotrace for providing the protections affordedto clients of Numis or for providing advice in connection with this announcementor any other matters referred to herein. This announcement does not constitute, or form part of, any offer for, or anysolicitation of any offer for, securities. Any acceptance or other response tothe Offer should be made only on the basis of information referred to in theOffer Document. The availability of the Offer to persons who are not resident in the UnitedKingdom may be affected by the laws of their relevant jurisdiction. Suchpersons should inform themselves of, and observe, any applicable legal orregulatory requirements of their jurisdiction. Further details in relation toOverseas Shareholders are contained in the Offer Document. Unless otherwise determined by 3M, the Offer is not being, and will not be,made, directly or indirectly, in or into or by the use of the mails of, or byany means or instrumentality (including, without limitation, telephonically orelectronically) of interstate or foreign commerce of, or through any facilitiesof a national securities exchange of any Restricted Jurisdiction if to do sowould constitute a violation of the relevant laws of such jurisdiction, and theOffer should not be accepted by any such use, means, instrumentality orfacilities or from or within the a Restricted Jurisdiction. Accordingly, copiesof this announcement are not being, and must not be mailed or otherwiseforwarded, distributed or sent in, into or from a Restricted Jurisdiction andall persons receiving this announcement (including nominees, trustees andcustodians) must not mail or otherwise forward, distribute or send it in, intoor from a Restricted Jurisdiction. Doing so may render invalid any purportedacceptance of the Offer. Notwithstanding the foregoing, 3M will retain the rightto permit the Offer to be accepted and any sale of securities pursuant to theOffer to be completed if, in its sole discretion, it is satisfied that thetransaction in question can be undertaken in compliance with applicable law andregulation. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Oct 20067:00 amRNSRule 8.3- Biotrace Int.
10th Oct 200610:31 amRNSEPT Disclosure
10th Oct 20067:00 amRNSRule 8.3- Biotrace Int.
9th Oct 20061:30 pmRNSRule 8.3 - Biotrace Int.
9th Oct 200610:49 amRNSEPT Disclosure
6th Oct 20065:59 pmRNSRule 8.1- Biotrace Intl-Amend
6th Oct 20061:26 pmRNSRule 8.3- Biotrace Intl. Plc
6th Oct 200611:54 amRNSEPT Disclosure
6th Oct 200611:00 amRNSEPT Disclosure
6th Oct 200610:58 amRNSEPT Disclosure
6th Oct 200610:55 amRNSOffer Update
6th Oct 200610:52 amRNSRule 8.1- Biotrace Int. PLC
6th Oct 20067:00 amRNSRule 8.3 - Biotrace Int.
5th Oct 200610:26 amRNSEPT Disclosure
4th Oct 20065:34 pmRNSOffer for Biotrace Intl PLC
26th Sep 200610:26 amRNSEPT Disclosure
25th Sep 200610:11 amRNSEPT Disclosure
22nd Sep 200610:38 amRNSEPT Disclosure - Amendment
21st Sep 200610:46 amRNSEPT Disclosure
20th Sep 200610:47 amRNSEPT Disclosure
19th Sep 200610:44 amRNSEPT Disclosure
18th Sep 200611:14 amRNSEPT Disclosure
15th Sep 20068:08 amRNSRule 2.10 Announcement
15th Sep 20067:55 amRNSStatement re Possible Offer
12th Sep 20064:38 pmRNSHolding(s) in Company
6th Sep 20067:01 amRNSInterim Results
14th Aug 20064:25 pmRNSAnnual Information Update
8th Aug 200612:18 pmRNSAnnual Information Update
1st Aug 20067:01 amRNSDirectorate Change
20th Jul 20067:01 amRNSTrading Update
31st May 20067:04 amRNSFinal Results
24th May 200610:23 amRNSHolding(s) in Company
18th May 200612:34 pmRNSHolding(s) in Company
15th May 20067:01 amRNSHolding(s) in Company
11th May 20061:58 pmRNSHolding(s) in Company
11th May 200611:36 amRNSResult of AGM
11th May 20068:02 amRNSAGM Statement
11th May 20067:01 amRNSAGM Statement
11th May 20067:01 amRNSNew Contract
10th May 20062:29 pmRNSAnnual Information Update
21st Apr 20067:00 amRNSCompletion of Property Sale
13th Apr 20065:26 pmRNSHolding(s) in Company
3rd Apr 20067:01 amRNSProperty Disposal
28th Mar 20068:43 amRNSNotifiable Interest
9th Mar 200612:37 pmRNSBlocklisting 6 Monthly Return
8th Mar 20067:04 amRNSAcquisition
1st Mar 20067:02 amRNSPreliminary Results
9th Feb 20067:01 amRNSDisposal of Ruskinn
6th Feb 20061:53 pmRNSHolding(s) in Company
30th Jan 200612:00 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.